Q4 2020 Immunovia AB (publ) Earnings Call Transcript
Welcome to the Immunovia Q4 Conference Call. (Operator Instructions)
Today, I'm pleased to present the CEO, Patrik Dahlen. Please, begin the meeting.
()-
Thank you, and good afternoon, everyone. Thank you for joining us today, and thank you for your continued interest in Immunovia. My name is Patrik Dahlen. I am the CEO of Immunovia and I will be presenting the full-year 2020 and quarter 4 results for Immunovia. Next page, Page 2.
Here, you can read our disclaimers and forward-looking statements, and I do encourage you to read these at your leisure. Next page, please, Page 3.
Today's agenda is as follows. I will start by discussing the importance of early detection of pancreatic cancer. Second, I will give you a summary of the full year 2020 and the quarter 4 highlights. Under this agenda point, I will discuss the status where we are right now with introduction of the IMMray PanCan-d test and the road to reimbursement.
I will then briefly touch upon our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
